Journal Of Neuroimmune Pharmacology

Journal Of Neuroimmune Pharmacology英文簡介

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

Journal Of Neuroimmune Pharmacology中文簡介

《Journal Of Neuroimmune Pharmacology》是一本由SPRINGER出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于2006年，刊期Quarterly，該刊已被國際權威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：神經(jīng)科學 3區(qū)；藥學 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q1。該刊發(fā)文范圍涵蓋神經(jīng)科學等領域，旨在及時、準確、全面地報道國內外神經(jīng)科學工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為7.285，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	3區(qū)	NEUROSCIENCES 神經(jīng)科學 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)	否	否

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q1	PHARMACOLOGY & PHARMACY	Q1	7.285
	NEUROSCIENCES	Q1

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
7.285	64	13.16%	71.67%	未開放	較慢,6-12周

IF值(影響因子)趨勢圖